Literature DB >> 16251990

Laboratory models of alcoholism: treatment target identification and insight into mechanisms.

David M Lovinger1, John C Crabbe.   

Abstract

Laboratory models, including animal tissues and live animals, have proven useful for discovery of molecular targets of alcohol action as well as for characterization of genetic and environmental factors that influence alcohol's neural actions. Here we consider strengths and weaknesses of laboratory models used in alcohol research and analyze the limitations of using animals to model a complex human disease. We describe targets for the neural actions of alcohol, and we review studies in which animal models were used to examine excessive alcohol drinking and to discover genes that may contribute to risk for alcoholism. Despite some limitations of the laboratory models used in alcohol research, these experimental approaches are likely to contribute to the development of new therapies for alcohol abuse and alcoholism.

Entities:  

Mesh:

Year:  2005        PMID: 16251990     DOI: 10.1038/nn1581

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  44 in total

1.  An investigation of the behavioral actions of ethanol across adolescence in mice.

Authors:  Kathryn Hefner; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2007-01-06       Impact factor: 4.530

Review 2.  Acute alcohol action and desensitization of ligand-gated ion channels.

Authors:  Alex M Dopico; David M Lovinger
Journal:  Pharmacol Rev       Date:  2009-03-06       Impact factor: 25.468

3.  Brain region-specific gene expression changes after chronic intermittent ethanol exposure and early withdrawal in C57BL/6J mice.

Authors:  Roberto I Melendez; Jacqueline F McGinty; Peter W Kalivas; Howard C Becker
Journal:  Addict Biol       Date:  2011-08-04       Impact factor: 4.280

4.  Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking.

Authors:  Katherine M Holleran; Hadley H Wilson; Tracy L Fetterly; Rebecca J Bluett; Samuel W Centanni; Rachel A Gilfarb; Lauren E R Rocco; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2016-01-11       Impact factor: 7.853

5.  Animated bird silhouette above the tank: acute alcohol diminishes fear responses in zebrafish.

Authors:  Ruxandra M Luca; Robert Gerlai
Journal:  Behav Brain Res       Date:  2012-01-16       Impact factor: 3.332

6.  Systems-level adaptations explain chronic tolerance development to nitrous oxide hypothermia in young and mature rats.

Authors:  Karl J Kaiyala; Shehzad Butt; Douglas S Ramsay
Journal:  Psychopharmacology (Berl)       Date:  2007-01-10       Impact factor: 4.530

7.  Review of current clinical biomarkers for the detection of alcohol dependence.

Authors:  Hamid R Tavakoli; Michael Hull; Lt Michael Okasinski
Journal:  Innov Clin Neurosci       Date:  2011-03

8.  Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: alcohol and CRF effects.

Authors:  Melissa A Herman; Marsida Kallupi; George Luu; Christopher S Oleata; Markus Heilig; George F Koob; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2012-12-04       Impact factor: 5.250

9.  A differential role for neuropeptides in acute and chronic adaptive responses to alcohol: behavioural and genetic analysis in Caenorhabditis elegans.

Authors:  Philippa Mitchell; Richard Mould; James Dillon; Steven Glautier; Ioannis Andrianakis; Christopher James; Amanda Pugh; Lindy Holden-Dye; Vincent O'Connor
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

10.  The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Malliga R Iyer; Luca Steardo; Luca Steardo; Kenner C Rice; Bruno Conti; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.